Pretreatment with β-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice
- 1 March 1995
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 29 (2) , 129-140
- https://doi.org/10.1016/0162-3109(94)00052-h
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Chronic Morphine Treatment Suppresses CTL-Mediated Cytolysis, Granulation, and cAMP Responses to AlloantigenBrain, Behavior, and Immunity, 1994
- Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activityJournal of Neuroimmunology, 1994
- Morphine inhibits signal transduction subsequent to activation of protein kinase C in mouse splenocytesLife Sciences, 1993
- Effects of morphine on the phenotypic expression of cell surface markers on murine lymphocytesLife Sciences, 1992
- Immunoregulatory effects of transforming growth factor-β in a prolonged period of cultureCellular Immunology, 1992
- Differential Effects of Morphine and Naltrexone on the Antibody Response in Various Mouse StrainsImmunopharmacology and Immunotoxicology, 1992
- Morphine-induced immune alterations in vivoCellular Immunology, 1990
- Role of Drug-Abuse Treatment in Limiting the Spread of AIDSClinical Infectious Diseases, 1988
- Immunosuppressive effects of chronic morphine treatment in miceLife Sciences, 1987
- A novel serine esterase expressed by cytotoxic T lymphocytesNature, 1985